This is why Summit Therapeutics (SMMT) is one of the Best Stocks to buy in a Rising Market

4 days ago 5

Abdul Rahman

Sat, May 2, 2026 astatine 1:29 PM CDT 2 min read

Summit Therapeutics (NASDAQ:SMMT) is one of the champion stocks to bargain successful a rising market, according to Wall Street analysts. On April 21, analysts astatine Stifel reiterated a Buy standing connected Summit Therapeutics (NASDAQ:SMMT) and a $45 terms target.

The affirmative stance comes connected the heels of Akeso announcing plans to disclose HARMONi-6 interim Overall Survival readout astatine ASCO 2026. The disclosure is to optimize the setup amended than erstwhile HARMONi-2 interim OS was disclosed past twelvemonth arsenic a effect of an NMPA approval.

This is wherefore  Summit Therapeutics (SMMT) is 1  of the Best Stocks to bargain  successful  a Rising Market

This is wherefore Summit Therapeutics (SMMT) is 1 of the Best Stocks to bargain successful a Rising Market

Romaset/Shutterstock.com

Unlike Harmoni 2, Harmoni-6 features 33% larger illustration size and all-squamous histology. The survey provides a archetypal look astatine an emerging OS from an ivonescimab Phase 3 proceedings randomized against anti-PD-1 tislelizumab. Last year, HARMONi-2 analyzed ivonescimab against monotherapy pembrolizumab successful patients with locally precocious oregon metastatic non-small compartment lung crab (NSCLC).

Akeso is seeking statement enlargement for Ivonescimab successful China, pursuing an interim investigation requested by Chinese wellness authorities that showed a clinically meaningful affirmative inclination favoring Ivonescimab implicit Pembrolizumab successful PD-L1.

Summit Therapeutics (NASDAQ:SMMT) is simply a clinical-stage biopharmaceutical institution focused connected processing caller oncology therapies to dainty serious, unmet aesculapian needs. Their superior absorption is the improvement and commercialization of ivonescimab, a imaginable first-in-class bispecific antibody targeting PD-1 and VEGF for the attraction of non-small compartment lung crab (NSCLC).

While we admit the imaginable of SMMT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 11 Best TSX Stocks to Buy According to Hedge Funds and 8 Best Australian Stocks to Buy successful 2026.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article